Aequus Pharmaceuticals Overview

  • Founded
  • 2013
  • Status
  • Public
  • Employees
  • 10
  • Stock Symbol
  • AQS
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $0.08
  • (As of Monday Closing)

Aequus Pharmaceuticals General Information


Aequus Pharmaceuticals Inc is a Canada based specialty pharmaceutical company. The firm's operating segments are Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. Aequus is developing a pipeline of products in neurology and psychiatry. The company's launched and pipeline products are Tacrolimus IR, Vistitan, AQS1304, AQS1303, and others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Delivery
Stock Exchange
Primary Office
  • 200 Granville Street
  • Suite 2820
  • Vancouver, British Columbia V6C 1S4
  • Canada
+1 (604) 000-0000

Aequus Pharmaceuticals Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aequus Pharmaceuticals Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.08 $0.09 $0.04 - $0.14 $8.9M 112M 221K -$0.02

Aequus Pharmaceuticals Financials Summary

In Thousands,
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 6,091 8,443 8,393 12,669
Revenue 1,511 1,230 1,088 878
EBITDA (1,022) (1,799) (2,022) (2,856)
Net Income (1,733) (2,340) (2,163) (2,991)
Total Assets 981 1,280 1,466 2,125
Total Debt 1,761 1,697 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aequus Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aequus Pharmaceuticals‘s full profile, request access.

Request a free trial

Aequus Pharmaceuticals Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Aequus Pharmaceuticals Inc is a Canada based specialty pharmaceutical company. The firm's operating segments are Commerc
Vancouver, Canada
10 As of 2018
000000000 000.00


lit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
Dublin, Ireland
00000 As of 0000
000 0000-00-00

000000 0

s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
0000 00000000
Parsippany, NJ
000 As of 0000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aequus Pharmaceuticals Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Perrigo Company Corporation Dublin, Ireland 00000 000000&0
000000 00000000000 Formerly VC-backed Parsippany, NJ 000 00000 00000000 00000
000000 00000000000 Corporation
0000 0000000000000 Corporate Backed or Acquired Haifa Bay, Israel 0000 0000 00000000000
To view Aequus Pharmaceuticals’s complete competitors history, request access »

Aequus Pharmaceuticals Executive Team (9)

Name Title Board Seat Contact Info
Donald McAfee Ph.D Chief Scientific Officer
Grant Larsen Chief Commercial Officer
Ian Ball Executive
Douglas Janzen Chief Executive Officer & Chairman
Ann Fehr Chief Financial Officer, Finance
You’re viewing 5 of 9 executive team members. Get the full list »

Aequus Pharmaceuticals Board Members (5)

Name Representing Role Since
Christopher Clark Self Board Member 000 0000
Douglas Janzen Self Chief Executive Officer & Chairman 000 0000
Jason Flowerday Self Board Member 000 0000
Rodoula Plakogiannis Aequus Pharmaceuticals Board Member 000 0000
To view Aequus Pharmaceuticals’s complete board members history, request access »

Aequus Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aequus Pharmaceuticals Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000-00000 000 11-Jan-2018 00000 0000000 Biotechnology 0000000 000000
TeOra Health 28-Jul-2015 Merger/Acquisition 00.000 Other Commercial Services 0000000 000000
To view Aequus Pharmaceuticals’s complete investments and acquisitions history, request access »